Huaguo's medical industry is lagging behind, mainly in two aspects.

First of all, the backwardness of medical technology, which is inseparable from the country's overall scientific and technological strength, from basic biochemistry to basic medicine, the gap between China and the United States is not a year, two years and three or five five-year plans can be smoothed, it takes a long time to accumulate. Similar to the advanced targeted cancer therapy in the United States, Huaguo cannot achieve it, similar to Bristol-Myers Squibb's PD-1 anti-tumor drugs, Huaguo does not have the technology to produce.

The second is that patents are backward, advanced medical technology first appeared in Western countries such as the United States, and others applied for global patent protection as soon as the technology appeared. After three or five years, when Huaguo has made a technological breakthrough in the same field, it is unable to produce and market new drugs due to the patent protection of the United States, which was the case of Novartis' Gleevec a few years ago, when Huaguo has technology but cannot produce it.

In response to the backward medical technology and the thirst of domestic patients, Huaguo has also taken many measures.

One of the most common measures is the initiation of national negotiations.

Huaguo negotiated with these pharmaceutical companies in the name of the state to reduce the price of these drugs and treatments in China.

The arrogance of Westerners is not something that can be forged in a day, and what they think about is not how many patients in China are struggling with poverty, and how many patients are waiting for advanced medical treatment. They only have profit in their eyes, and a new anti-cancer drug interview from the technical theory to the final clinical trial will cost the pharmaceutical company billions of dollars, and the pharmaceutical company will definitely increase the selling price during the 20-year patent protection period, earn back the cost and obtain profits. Capitalists are not philanthropists, and this is true anywhere in the world.

So is Huaguo useful for state negotiations for pharmaceutical companies?

It doesn't work.

The usefulness lies in the fact that the price of drugs such as Novartis Gleevec has been reduced from 40,000 RMB a bottle to 20,000 RMB a bottle, but the country has to sacrifice a considerable part of the cost for this, such as strengthening domestic drug intellectual property rights, prohibiting other similar drugs from being marketed in China, reducing the export trade surplus with Europe, etc., this sacrifice is invisible.

It is useless because it is similar to PD-1 to treat oncology drugs, and national negotiations are useless, and the price is still so high. This type of drug is high-tech and cannot be imitated, so you don't like to buy it. The sale of PD-1 drugs is not allowed in China, and countless patients obtain expensive drugs through smuggling, medical tourism, etc. Western pharmaceutical companies will still make big money.

If there is no Bluestar Group now, Western pharmaceutical companies will always maintain such profits, and third world countries will always be at the bottom end of the pharmaceutical field.

Now that the Bluestar Group has appeared, Western pharmaceutical companies are nervous.

The treatment of liver cancer, lung cancer, stomach cancer and other cancers has always been a key profit project of Squibb and other rice pharmaceutical companies, and now as soon as the Bluestar Group appears, patients will find a way to go to Jiangcheng People's Hospital, and will find a way to seek help from Bluestar Biomedical Functional Company, instead of looking for Squibb, who is proud of his high cost and attitude.

According to a statistic conducted by Squibb Company, in just two months, 90% of patients want to go to Huaguo for treatment if conditions permit. The treatment fee of hundreds of thousands is a piece of cake for patients in the United States.

Moreover, it must be made clear that the treatment effect of Bluestar Group is for life, while Squibb's treatment is carried out every year, and more than one million RMB can only be managed for one year.

When comparing the cost and treatment effect, which is cost-effective, patients certainly have a scale in their hearts.

This time, Squibb Company went to Huaguo Bluestar Group, which also represented the United States to explore the wind.

The best option is that Squibb hopes to introduce Bluestar Group's gene therapy technology to achieve the cooperation between the two parties.

The next best option is for Squibb to trade the rights of high-priced anti-cancer drugs in the Asia-Pacific region and the rights of Bluestar gene therapy in the United States.

The worst result is that the two sides cannot reach an agreement at all, and the United States Pharmaceutical Company, represented by Squibb Company, will take measures against the Bluestar Group to protect its own interests.

Don't look at the fact that everyone is talking about business with a smile now, when it really involves their own interests, it is a real knife and a real gun, and it is a scene of life and death.

Xiao Ping was waiting for Chen Nuo in the waiting room, and when she saw Chen Nuo coming in, Xiao Ping stood up and shook hands with Chen Nuo.

"Chen Dong, I can be regarded as waiting for you. Knowing that you are a busy person, I made an appointment with you a month in advance. Xiao Ping is dressed as a professional woman, although she is over forty years old, her charm still exists.

If a woman can achieve Xiao Ping's position, she will definitely make efforts that ordinary people can't achieve.

Chen Nuo doesn't know many female executives, Liu Mei counts as one, and Xiao Hui counts as the second.

This unique temperament of this woman gives her a radiant charm.

may be the reason for using microorganisms to clean the mud, Xiao Ping looks very young, forty years old is just a number.

"Ahem, uh-huh!" Jiang Li coughed twice beside him to remind Chen Nuo, but he was muttering in his heart, what the hell is going on with the boss, he doesn't even look at a young girl when he meets him, and he stares intently when he meets a middle-aged woman in the workplace, what the hell is this.

Does the boss have a special fetish? Jiang Li didn't dare to think about it, so she had to quietly talk to her good friend Yang Maixi, so that Yang Maixi, who was stupid and simply scary, would start early!

Chen Nuo came back to his senses, felt a little rude, and smiled apologetically at Xiao Ping.

He stared at Xiao Ping just now, not because Xiao Ping was attractive and beautiful, but because he was thinking about the future medical trade of Bluestar Group in the United States.

Bluestar Biology and Medicine Company has attracted the attention of the Western society, and Bristol-Myers Squibb is just here to explore the reality of the Bluestar Group, and according to the urine nature of the people of the United States, they will definitely find trouble with the Bluestar Group.

From chips to garbage disposal issues, to Wukong electric vehicles, the hearts of the Chinese people are actually holding their breath. If the Blue Star Group does it again in the medical field that the people of the United States are proud of, the people of the United States will really be very angry.

Xiao Hui explained the intention of this time, Squibb is here to seek technical cooperation with Bluestar, and Squibb hopes to become the agent of Bluestar Biotechnology and Medicine in North America.

Xiao Hui said: "Chen Dong should know that it takes many procedures to market a drug or a treatment plan in the United States, from theory to animal experiments to approval by the medical association to enter the clinic, at least five years, more than ten or twenty years. Although Bluestar Group's gene therapy has been successful, your operating procedures are completely inconsistent with the regulations of the United States and the European Union, and according to the current progress of your company's gene therapy, there is no way to market it in the United States. ”

Keep in mind that the first domain name :.com this book. The mobile version of the mobile version of the wonderful book house is :.com